A significant upregulation of SOD1 in nasopharyngeal carcinoma (NPC) tissue is observed and high SOD1 expression is a predictor of poor prognosis and is correlated with poor outcome, indicating that SOD1 is a potential prognostic biomarker and a promising target for NPC therapy (40). This evidence concerns the gene SOD1 and nasopharyngeal carcinoma.